Leadership changeRegulatory filing
What was reported
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · Jun 30, 2026 · Open the source ↗
What the evidence supports
Vivani Medical told the SEC (Form 8-K, Item 5.02) that there was a change involving its directors or officers, or their pay arrangements. The filing gives Jun 24, 2026 as the date of the earliest event reported.
What remains unknown
The reasons for the change beyond those stated, and what it means for the company's strategy or results.
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Form 8-K, Item 5.02 textDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · Jun 30, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:52 UTC
Vivani Medical reports changes involving its directors or officers (Form 8-K, Item 5.02)
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.